Search

everythinglearnresearchcommunity

for

Search:↓

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

The study found that diseases can be grouped by symptoms and that the accuracy of predicting disease-related genes varies with the data source.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

SHBG may be a useful early indicator and treatment target for PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

PRP may help reduce musculoskeletal pain, but its effectiveness is still uncertain.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.